|
|
| |
| |
|
|
Update to “Palivizumab (Synagis) Prior Authorization Criteria to Change for Texas Medicaid”
Information posted September 11, 2009: This is an update to an article that was published on this website on August 28, 2009, titled "Palivizumab (Synagis) Prior Authorization Criteria to Change for Texas Medicaid." The article stated that the respiratory syncytial virus (RSV) season in the second region is expected to start no earlier than November 1 of each calendar year. The November 1 start date applies only to regions 1, 9, and 10.
In addition, TMHP will allow a grace period for palivizumab (Synagis) prior authorization requests and will accept requests submitted on the old form until November 1, 2009. Beginning November 1, 2009, providers must submit the revised Texas Medicaid Palivizumab (Synagis) Prior Authorization Request Form, which is available in the Provider Forms section of this website.
For more information, call the TMHP Contact Center at 1-800-925-9126.
|
 |
 |
|
|
|
|
|